Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/24 18:48 | 5/2/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Ganot Ilan | MA | D | 5 | S.d | -26 | 6.85 | 0 | -4 | 124 | I | ||||||||||||||||
1/11/24 17:43 | 1/9/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Tan Kevin | MA | O | CFO,Trea | 1 | S.d | -32 | 8.20 | 0 | -4 | 9 | D | |||||||||||||||
12/5/23 14:40 | 12/4/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Cumbo Alexander | MA | DO | P,CEO | 1 | S.d | -33 | 2.77 | 0 | -12 | 17 | D | |||||||||||||||
12/5/23 14:32 | 12/4/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Howton David T | MA | O | COO | 1 | S.d | -15 | 2.78 | 0 | -5 | 8 | D | |||||||||||||||
12/5/23 14:31 | 12/4/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Herzich Paul | MA | O | CTO | 1 | S.d | -8 | 2.77 | 0 | -3 | 4 | D | |||||||||||||||
12/5/23 14:30 | 12/4/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Hanrahan Jessie | MA | O | Chief Re | 1 | S.d | -14 | 2.78 | 0 | -5 | 7 | D | |||||||||||||||
12/5/23 14:30 | 12/4/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Marlowe Jennifer | MA | O | CSO | 1 | S.d | -14 | 2.77 | 0 | -5 | 7 | D | |||||||||||||||
1/31/23 21:18 | 1/27/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Morris Carl Ashley | MA | O | Chief Sc | 1 | S.d | -3 | 7.49 | 0 | 0 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |